James N. Wilson's most recent trade in Corcept Therapeutics Inc was a trade of 25,000 Stock option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc | James N. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 25,000 | 25,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jan 2025 | 7,800 | 1,445,168 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.29 per share. | 22 Jan 2025 | 250,000 | 250,000 (0%) | 0% | 3.3 | 822,500 | Common Stock |
| Corcept Therapeutics Inc | James N. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 250,000 | 0 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 22 Jan 2025 | 146,742 | 1,452,968 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Jan 2025 | 146,742 | 0 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.03 per share. | 22 Jan 2025 | 103,258 | 146,742 (0%) | 0% | 59.0 | 6,095,320 | Common Stock |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Dec 2024 | 7,800 | 1,306,226 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 May 2024 | 2,000 | 1,314,026 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 80,000 | 80,000 | - | - | Employee stock option (right to buy) | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 80,000 | 80,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 12,000 | 1,319,026 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2022 | 300,000 | 0 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 14 Jun 2022 | 300,000 | 300,000 (0%) | 0% | 2.1 | 624,000 | Common Stock |
| Corcept Therapeutics Inc | James N. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2022 | 168,181 | 1,331,026 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 14 Jun 2022 | 168,181 | 168,181 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.10 per share. | 14 Jun 2022 | 131,819 | 168,181 (0%) | 0% | 21.1 | 2,781,381 | Common Stock |
| Corcept Therapeutics Inc | James N. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 45,000 | 90,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2022 | 12,000 | 1,162,845 (1%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) |